CNC
Centene · Sep 17, 2026
$67.31
Shares
No view
No fair value for CNC today: only 3 of 4 models has usable inputs, and one model is a guess.
How we value it ›Prices as of 2:48 PM ET, Sep 17. Check the live quote before you send an order.
The put
Skip
Skip the put. The money looks good, but CNC swings more than it pays. Want CNC? Buy shares.
If it goes against you: you buy 100 shares at $65, which after the $200 you keep works out to $63.00 a share. Below $63.00 you are down on the trade. From that day the shares take above is the one that applies.
The order, if you sell it anyway
You get$200 (limit about $2.00)
If it fallsBuy 100 shares at $65
Cash to hold$6,500
Close earlyBuy back at about $0.80 ($80)
Chance you buy the sharesabout 35 in 100
ContractCNC Oct 16 $65 put
ActionSell to open
In your broker app: open the stock → Trade → Options → Sell to open → pick the contract shown here.
Why skip
The put: Oct 16, $65 strike, 29 days out. Pays $200. Roughly a 35-in-100 chance you end up buying the shares.
On paper: 39% a year. That number assumes CNC keeps moving like it did the past two years. Take that away and it is -11% a year. That is why we say skip.
Next earnings Oct 27, after this put ends. We never sell a put across a report.
If you already own 100 shares
Income call
For income on CNC you already hold: sell the Oct 9 $76 call and take $60 now. If CNC climbs to $76 by Oct 9, your 100 shares are sold at $76, so only do it if you're happy selling there.
If it climbs past $76 your 100 shares are sold at $76 and you keep the $60. That is the trade working, not a loss.
The call order
ActionSell to open
ContractCNC Oct 9 $76 call
You get$60 (limit about $0.60)
If it climbsYour 100 shares sell at $76
Chance your shares are soldabout 16 in 100
After removing the trend-21% a year
First take on CNC. Result Oct 16. See the record
Everyone sees the same card. It is not advice for you personally. You can lose more than you collect.
PrivacyTermsHow to read thisHow we value itThe recordPerformance简体中文繁體中文한국어日本語DipBell by cleo research